ZA969351B - Organic compositions - Google Patents

Organic compositions

Info

Publication number
ZA969351B
ZA969351B ZA969351A ZA969351A ZA969351B ZA 969351 B ZA969351 B ZA 969351B ZA 969351 A ZA969351 A ZA 969351A ZA 969351 A ZA969351 A ZA 969351A ZA 969351 B ZA969351 B ZA 969351B
Authority
ZA
South Africa
Prior art keywords
organic compositions
composition
active agent
pharmaceutically active
dissolved
Prior art date
Application number
ZA969351A
Other languages
English (en)
Inventor
Steven Poile
Julian Earle Harrison
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of ZA969351B publication Critical patent/ZA969351B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA969351A 1995-11-08 1996-11-07 Organic compositions ZA969351B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9522885A GB2306885B (en) 1995-11-08 1995-11-08 Supersaturated Pharmaceutical Compositions

Publications (1)

Publication Number Publication Date
ZA969351B true ZA969351B (en) 1997-06-02

Family

ID=10783584

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969351A ZA969351B (en) 1995-11-08 1996-11-07 Organic compositions

Country Status (8)

Country Link
EP (1) EP0862417B1 (de)
AT (1) ATE233085T1 (de)
AU (1) AU7315596A (de)
DE (1) DE69626401T2 (de)
ES (1) ES2189886T3 (de)
GB (1) GB2306885B (de)
WO (1) WO1997017062A1 (de)
ZA (1) ZA969351B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
SE9801704D0 (sv) 1998-05-14 1998-05-14 Bioglan Ab Biologically active composition
SE9801705D0 (sv) * 1998-05-14 1998-05-14 Bioglan Ab Biologically active composition
BRPI0307786B8 (pt) * 2002-02-26 2021-05-25 Astrazeneca Ab composição farmacêutica, método para preparar a mesma, métodos para inibir a taxa de precipitação do agente da solução no trato gi, e para reduzir variabilidade inter-pacientes no que se refere à biodisponibilidade e/ou concentrações plásmáticas do agente, e, uso de um celulose éter solúvel em água ou de um éster de um celulose éter solúvel em água
FR2880269B1 (fr) * 2004-12-31 2008-11-07 Cardon Pharmaceuticals Nv Sa Produit traitant pour animaux et moyens pour sa preparation
WO2008098158A1 (en) * 2007-02-08 2008-08-14 Dermworx, Incorporated Local anti-infective agent for treatment of nail fungal infections
JP2018519294A (ja) * 2015-06-22 2018-07-19 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｃｏｎｓｕｍｅｒ Ｉｎｃ． 皮膚に有益な効果を与えるための多層局所適用物品

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
JPS61238724A (ja) * 1985-04-16 1986-10-24 Hokuriku Seiyaku Co Ltd 消炎鎮痛外用液剤
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
GB8629640D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
JPH08268892A (ja) * 1995-03-30 1996-10-15 Yuuwa Shoji:Kk 水溶液製剤及びその製造方法

Also Published As

Publication number Publication date
GB2306885A (en) 1997-05-14
WO1997017062A1 (en) 1997-05-15
EP0862417A1 (de) 1998-09-09
EP0862417B1 (de) 2003-02-26
ATE233085T1 (de) 2003-03-15
ES2189886T3 (es) 2003-07-16
DE69626401T2 (de) 2003-10-30
GB2306885B (en) 1999-07-14
DE69626401D1 (de) 2003-04-03
GB9522885D0 (en) 1996-01-10
AU7315596A (en) 1997-05-29

Similar Documents

Publication Publication Date Title
IS4675A (is) Örþeytur til að nota sem burðarefni við inngjöf virkra efna
HK1003978A1 (en) Composition for the treatment of schizophrenia
ZA964735B (en) Compositions and methods for topical administration of pharmaceutically active agents
CA2282345A1 (en) Pharmaceutical composition
NO304261B1 (no) Preparat omfattende en lipofil forbindelse
CA2289717A1 (en) Novel therapy for constipation
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
WO2002002056A3 (en) Method of treatment of seborrheic dermatitis
EP0347864A3 (de) Antiatherosklerose-Mittel
ZA969351B (en) Organic compositions
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
NO962619L (no) Psoriasisbehandling
BR9908155A (pt) Composto, composição farmacêutica, uso do composto, e, processo para intensificar cognição em um sujeito sofrendo de cognição diminuìda
TW238246B (en) Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor
UA39988C2 (uk) Антимікробний засіб" асперсепт" та спосіб лікування та профілактики інфекційних уражень шкіри за допомогою цього засобу
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence
MY110416A (en) Composition for the treatment of schizophrenia.
IT1270641B (it) Uso della midesteina come cicatrizzante e composizioni farmaceutiche topiche relative
KR960010004A (ko) 두통 예방 및 치료제 조성물
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
ITRM940505A0 (it) "agente attivo per il trattamento di infezioni croniche da immunodepressione e per contrastare lo sviluppo di tumori favoriti da immunodepressione".
MX9601756A (es) Composicion liquida estable que contiene urato-oxidasa, y composicion liofilizada para su preparacion.